(MENAFN- IMARC Group)
The latest report by IMARC Group, titled“ Remote Patient Monitoring Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2024-2032 “, The global remote patient monitoring market size reached US$ 1.5 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 4.7 Billion by 2032, exhibiting a growth rate (CAGR) of 13.4% during 2024-2032.
Remote Patient Monitoring (RPM) employs cutting-edge technology to remotely oversee a patient's health status. It encompasses the gathering, analysis, and transmission of patient data to healthcare providers, facilitating continuous tracking of vital signs, symptoms, and other health indicators. This innovative method has become increasingly vital in modern healthcare, addressing the escalating demand for personalized, instantaneous care. RPM typically incorporates diverse home-based devices and sensors, such as wearable fitness trackers, blood pressure monitors, and glucose meters. These devices gather data, which is securely transmitted to healthcare professionals for real-time evaluation, enabling prompt interventions and adjustments to treatment strategies. Consequently, this approach minimizes the necessity for frequent in-person consultations and hospital admissions.
Remote Patient Monitoring Market Trends and Drivers:
The rise in the aging population globally is resulting in an increase in chronic diseases, necessitating continuous monitoring of healthcare. Remote Patient Monitoring (RPM) plays a crucial role in effectively managing chronic conditions, thereby stimulating market expansion. Moreover, RPM contributes to cost reduction in healthcare by lowering hospital readmissions, emergency room visits, and the necessity for face-to-face consultations. This potential for cost savings serves as a significant incentive for healthcare providers and payers to embrace RPM. Furthermore, the pandemic has hastened the adoption of telehealth and remote monitoring solutions due to their ability to provide safer patient care while reducing exposure to viruses. This heightened recognition and acceptance have propelled market growth. Additionally, patients are taking a more proactive approach towards their health and are increasingly inclined towards the convenience of RPM, enabling them to manage their conditions from the comfort of their homes. This growing demand is pushing healthcare providers to offer RPM services as well.
For an in-depth analysis, you can refer sample copy of the report: https://www.imarcgroup.com/remote-patient-monitorning-market/requestsample
Report Segmentation:
The report has segmented the market into the following categories:
Breakup by Device Type:
Blood Pressure Monitor Glucose Monitor Heart Rate Monitor Pulse Oximeters Respiratory Monitor Others
Breakup by Application:
Cancer Treatment Cardiovascular Diseases Treatment and Monitoring Diabetes Treatment Sleep Disorder Treatment Weight Management and Fitness Monitoring Others
Breakup by End-Use:
Hospitals and Clinics Homecare Settings Others
Market Breakup by Region:
North America (United States, Canada) Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, Others) Europe (Germany, France, United Kingdom, Italy, Spain, Russia, Others) Latin America (Brazil, Mexico, Others) Middle East and Africa
Competitive Landscape with Key Player:
Abbott Laboratories AMD Global Telemedicine Inc. BIOTRONIK SE & Co. KG Boston Scientific Corporation Dexcom, Inc. GE Healthcare Inc. (Danaher Corporation) Honeywell International Inc. Koninklijke Philips N.V. Medtronic Inc. Nihon Kohden Corporation OSI Systems Inc. Roche Holding AG
Note: If you need specific information that is not currently within the scope of the report, we will provide it to you as a part of the customization.
About Us
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC's information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company's expertise.
Our offerings include comprehensive market intelligence in the form of research reports, production cost reports, feasibility studies, and consulting services. Our team, which includes experienced researchers and analysts from various industries, is dedicated to providing high-quality data and insights to our clientele, ranging from small and medium businesses to Fortune 1000 corporations.
Contact Us:
IMARC Group
134 N 4th St. Brooklyn, NY 11249, USA
Email:
Tel No:(D) +91 120 433 0800
United States: +1-631-791-1145 |United Kingdom: +44-753-713-2163
MENAFN13032024004122016232ID1107970049
Legal Disclaimer:
MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.